LXEO: Lexeo Therapeutics, Inc. Net Sales Margin

Public company logo of Lexeo Therapeutics, Inc. (LXEO)

Fierce competition for patients in the gene therapy sector is impacting the price action of Lexeo Therapeutics (LXEO), and the net profit margin underscores these challenges, where the 0.00 level captures the current state. Stability is provided by the parallel development of Alzheimer's and cardiology drugs. Meanwhile, the upgraded capacities of vector manufacturing partners guarantee uninterrupted product output.

LXEO: Lexeo Therapeutics Inc. Net Sales Margin 02/21/2024 - 11/19/2026

Summary analytical data breakdowns for lexeotx.com (LXEO)

- market value and analyst target forecast:
Basic company analysis:Lexeo Therapeutics
Flagship merchandise of Lexeo Therapeutics

Institutional capital evaluates Lexeo Therapeutics (LXEO) through the lens of capital management efficiency during its pre-revenue phase. By analyzing the company's net margin profile, investors can discern the profit share remaining after all expenses, which for this biotech reflects the burn rate of cash reserves on capital expenditures, thereby determining the pace of liquidity depletion and the overall resilience of the asset.

Competitors of Lexeo Therapeutics (LXEO)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX